Dipesh Uprety
Wayne State University
H-index: 15
North America-United States
Top articles of Dipesh Uprety
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Annals of Oncology
2024/1/1
Mahmoud Abdelsalam
H-Index: 8
Patrick Alexander
H-Index: 5
Georges Azzi
H-Index: 5
Penelope Bradbury
H-Index: 23
Antonio Chella
H-Index: 17
Nicholas Farrell
H-Index: 0
Kai He
H-Index: 16
Chao Huang
H-Index: 2
Emad Ibrahim
H-Index: 1
Melissa Johnson
H-Index: 3
Benjamin Jones
H-Index: 1
Swati Kulkarni
H-Index: 19
Tarek Mekhail
H-Index: 9
Alessandro Morabito
H-Index: 4
David Park
H-Index: 22
Eric Schaefer
H-Index: 24
Malignant Pericardial Effusion, or Fluid Around the Heart Due to Cancer
JAMA oncology
2024/1/1
Dipesh Uprety
H-Index: 9
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
The Lancet Oncology
2024/4/1
Dipesh Uprety
H-Index: 9
Qi Yan
H-Index: 1
A challenging case of stage IV EGFR-mutant lung cancer with histologic transformation and multiple resistance mechanisms
Current Problems in Cancer: Case Reports
2024/2/2
Dipesh Uprety
H-Index: 9
First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non–Small-Cell Lung Cancer: Are We Ready to Use It?
Journal of Clinical Oncology
2024/2/1
Dipesh Uprety
H-Index: 9
Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung Cancer
New England Journal of Medicine
2024/1/11
ABIM Maintenance of Certification—Reply
JAMA
2023/12/19
Dipesh Uprety
H-Index: 9
Assessment of Efficacy and Safety of EGFR-TKIs in African American Patients with EGFR-mutated NSCLC
International Journal of Cancer Care and Delivery
2023/12/7
Kevin Chang
H-Index: 4
Dipesh Uprety
H-Index: 9
529 Impact of histology and PD-L1 status on immune checkpoint inhibitors in the treatment of non-small cell lung cancer
2023/11/1
Dipesh Uprety
H-Index: 9
Hirva Mamdani
H-Index: 7
P1. 12-08 Characterization of MET Exon 14 Skipping Analog (Y1003) in Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
2023/11/1
EP11. 01-10 Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer: Does Histology Matter?
Journal of Thoracic Oncology
2023/11/1
Maintenance of Certification (MOC)—Benefit vs Burden
JAMA
2023/10/10
Dipesh Uprety
H-Index: 9
151P Baseline circulating tumor DNA (ctDNA) biomarker analysis of patients with human epidermal growth factor receptor 2 (HER2)-overexpressing metastatic non–small cell lung …
Annals of Oncology
2023/10/1
Sclerodermatous eruption in a patient with metastatic colon cancer treated with an FLT3/CDK inhibitor
Australasian Journal of Dermatology
2023/8
ChatGPT—a promising generative AI tool and its implications for cancer care
Cancer
2023/8/1
Dipesh Uprety
H-Index: 9
Dongxiao Zhu
H-Index: 17
Perioperative therapy for resectable non–small-cell lung cancer: Weighing Options for the present and future
2023/7
Dipesh Uprety
H-Index: 9
Impact of CLEC3B mRNA expression on genetic landscape and immune tumor-microenvironment in NSCLC.
2023/6/1
The role of adjuvant chemotherapy (CT) for early stage resectable node negative small cell lung cancer with size of≤ 2 cm post-surgical resection: A SEER plus based …
2023/6/1
Dipesh Uprety
H-Index: 9
Surgery with adjuvant chemotherapy versus chemoradiation for early-stage large cell neuroendocrine cancer (LCNEC) of the lung: A SEER plus based analysis.
2023/6/1
Anish Shah
H-Index: 1
Dipesh Uprety
H-Index: 9
Role of adjuvant chemotherapy (CT) in node negative 4-5 cm non-small cell lung cancer in elderly population.
2023/6/1
Dipesh Uprety
H-Index: 9
